Covered recipient · General Payments record
SARAH A STOUT
Physician Assistants & Advanced Practice Nursing Providers Physician Assistant
General Payments · PY2021–2024
$1,150.23
- Reported across 52 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $416.23 | 17 |
| Education | $8.90 | 1 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Novo Nordisk AS | $227.39 | 7 |
| Lilly USA, LLC | $53.33 | 3 |
| VIVUS LLC | $33.35 | 2 |
| Ethicon US, LLC | $22.84 | 1 |
| Takeda Pharmaceuticals U.S.A., Inc. | $21.64 | 1 |
| ABBVIE INC. | $19.16 | 1 |
| AIMMUNE THERAPEUTICS, INC. | $16.19 | 1 |
| Pacira Pharmaceuticals Incorporated | $15.78 | 1 |
| INTRA-SANA LABORATORIES | $15.45 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (18)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $19.16 | 02/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108262133 | CMS |
| AIMMUNE THERAPEUTICS, INC. | $16.19 | 05/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1146970195 | CMS |
| Ethicon US, LLC | $22.84 | 06/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1077637392 | CMS |
| Intra-Sana Laboratories | $15.45 | 10/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1138622578 | CMS |
| Lilly USA, LLC | $16.02 | 05/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135862213 | CMS |
| Lilly USA, LLC | $21.08 | 08/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135931680 | CMS |
| Lilly USA, LLC | $16.23 | 09/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135862217 | CMS |
| Novo Nordisk Inc | $15.55 | 01/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100316584 | CMS |
| Novo Nordisk Inc | $123.88 | 03/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100497283 | CMS |
| Novo Nordisk Inc | $15.83 | 04/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100458956 | CMS |
| Novo Nordisk Inc | $8.90 | 05/16/2024 | Education | Undisputed | 01/23/2026 | 1100563649 | CMS |
| Novo Nordisk Inc | $17.00 | 05/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100538850 | CMS |
| Novo Nordisk Inc | $21.45 | 08/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100239718 | CMS |
| Novo Nordisk Inc | $24.78 | 11/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100534899 | CMS |
| Pacira Pharmaceuticals Incorporated | $15.78 | 07/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1151272959 | CMS |
| Takeda Pharmaceuticals U.S.A., Inc. | $21.64 | 01/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1137829749 | CMS |
| VIVUS LLC | $16.04 | 04/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1129421279 | CMS |
| VIVUS LLC | $17.31 | 11/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1129421281 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.